Glomerulus-Targeted ROS-Responsive Polymeric Nanoparticles for Effective Membranous Nephropathy Therapy

Area of Science:

• Biomaterials Science
• Nanomedicine
• Nephrology

Background:

• Membranous nephropathy (MN) is a leading cause of kidney failure, driven by immune deposits and podocyte damage.
• Reactive oxygen species (ROS) exacerbate podocyte injury in MN progression.
• Celastrol (CLT) shows therapeutic potential but is limited by toxicity.

Purpose of the Study:

• To design and evaluate ROS-responsive cationic polymeric nanoparticles (PPS-CPNs) for targeted delivery of CLT in MN.
• To assess the efficacy and safety of CLT-loaded PPS-CPNs in a rat MN model.

Main Methods:

• Synthesized ROS-responsive PPS-CPNs using PPS-PEG and PPS-PEI for CLT encapsulation.
• Investigated nanoparticle biodistribution, cellular uptake, and drug release mechanisms.
• Evaluated therapeutic effects on kidney pathology and systemic toxicity in a rat MN model.

Main Results:

• PPS-CPNs demonstrated efficient glomerular accumulation and podocyte internalization.
• ROS triggered rapid CLT release within podocytes, enhancing therapeutic efficacy.
• CLT-loaded PPS-CPNs significantly alleviated MN-related kidney damage and reduced organ toxicity compared to free CLT.

Conclusions:

• ROS-responsive nanotherapy offers a targeted and safer approach for MN treatment.
• Encapsulating CLT in PPS-CPNs improves therapeutic outcomes and minimizes off-target effects.
• This nanomedicine strategy holds promise for managing membranous nephropathy.